
NHI Stock Forecast & Price Target
NHI Analyst Ratings
Bulls say
National Health Investors is expected to experience growth in the coming years, with its deep investment pipeline, low-levered balance sheet, and below-average cost of capital as main factors contributing to this growth. Despite recent events such as the non-cash write-off of straight-line rent and the sale of its NHC portfolio, the company remains undervalued and presents an attractive entry point into a multi-year growth story. However, there are potential risks such as underperformance if rent resets are lower than anticipated or if there is weaker deferred rent collection, and investors may need to show patience for the company to rebuild its NOI to pre-deal levels after the sale of the NHC portfolio. In the long run, the company's decision to prioritize improved growth over short-term market gains is the right strategic move for its future success.
Bears say
National Health Investors is facing a negative outlook due to lowered FFO estimates for 2026 and 2027, which reflect a decline in normalized FFOps in 2026 followed by a modest growth in 2027. This is primarily due to the dilution caused by the portfolio sale with proceeds being used to repay debt rather than being reinvested. Moreover, the company's high dependence on its top few operators and recent disappointing results for its existing SHOP portfolio also contribute to the negative outlook. However, the company has potential for growth through new investments and organic growth in the senior housing and healthcare sector.
This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.
NHI Analyst Forecast & Price Prediction
Start investing in NHI
Order type
Buy in
Order amount
Est. shares
0 shares